What Arine does

Arine, Inc. is a San Francisco-based, venture-backed healthcare AI company founded in 2017 that applies artificial intelligence to medication therapy optimization for health plans, PBMs, and at-risk provider organizations. Its platform integrates clinical, behavioral, and social determinants of health (SDoH) data — including pharmacy and medical claims, cost and quality data, lab data, and contextual inputs such as voice patterns — to produce prioritized, personalized medication recommendations and care plans at population scale. The platform is delivered through a core Arine Platform and four named solution modules: LUMINATE (high-risk patient management), RESONATE (prescriber analytics), ELEVATE (quality improvement and CMS Star Ratings), and an MTM module focused on medication therapy management and care team efficiency.

Under the hood, Arine combines predictive analytics, anomaly/outlier detection, recommendation engines, process automation, and clinical knowledge retrieval in continuous-learning feedback loops, with hundreds of data features per model and reported output of more than 40 million recommendations annually across 30+ million client lives. The Arine Portal holds HITRUST Risk-based, 2-year (r2) certification, addressing healthcare security and compliance requirements demanded by health plan and provider buyers.

Arine sells primarily through an enterprise field-sales motion targeting senior clinical, pharmacy, and population-health buyers at health plans and provider systems, with quote-based, outcomes-aligned multi-year contracts rather than publicly listed pricing. Named customers include SCAN Health Plan, Oklahoma Health Care Authority, VNS Health, Desert Oasis Healthcare, and Magellan Health, and the company reports 45+ health plan clients spanning five national health plans, seven Blues plans, and two national PBMs across Medicare, Medicaid, Special Needs, and Commercial populations. The company has raised approximately $70 million across a $11M Series A (2021), $29M Series B led by 111° West Capital (August 2022), and $30M Series C led by Town Hall Ventures (June 2025), employs 101–250 people distributed across the United States, and is led by co-founders Yoona Kim, PharmD/PhD (CEO) and Penjit "Boom" Moorhead (CTO).

Name

Arine

Legal name

Arine, Inc.

Website

https://arine.io

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

101–250 employees

Short description

Arine is a healthcare AI SaaS company that uses artificial intelligence to optimize medication therapy for health plans, PBMs, and at-risk providers by integrating clinical, behavioral, and social data into personalized medication recommendations across Medicare, Medicaid, Special Needs, and Commercial populations.

Ownership category

akta.pro rank

Product category

Healthcare Medication Intelligence Software

NAICS

Software Publishers (513210), Custom Computer Programming Services (541511), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ)

akta.pro secondary industries

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)

Keywords

• Medication intelligence
• Medication optimization
• Healthcare AI platform
• Value-based care software
• Clinical decision support

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Healthcare SaaS subscriptions (value-based contracts with health plans and providers): Arine is described as a healthcare SaaS platform. Revenue comes from enterprise contracts with health plans, Blues plans, national PBMs, and at-risk provider organizations. Pricing is quote-based and outcome-aligned, evidenced by 'guaranteed outcomes', 'Immediate ROI' framing, and client outcome metrics (e.g., reduced total cost of care, reduced hospitalizations, 4-5 star ratings).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Arine provides an AI-driven medication intelligence platform that integrates clinical, behavioral, and social (SDoH) data to deliver prioritized, personalized medication recommendations for health plans and at-risk provider organizations. The platform is delivered through three core solution modules—LUMINATE for high-risk patient management, RESONATE for prescriber analytics, and ELEVATE for quality improvement and MTM—sold as recurring SaaS subscriptions with outcomes-based contracts.

Product overview

Arine offers a single integrated AI-driven medication intelligence platform composed of the core Arine Platform plus three named solution modules (LUMINATE, RESONATE, and ELEVATE) that can each stand on their own or be combined to maximize impact. The core platform merges clinical, behavioral, and social data with deep clinical experience to deliver personalized medication recommendations; LUMINATE focuses on high-risk high-cost patient management, RESONATE delivers prescriber analytics to extend reach through providers, and ELEVATE drives quality improvement and Medication Therapy Management (MTM) to achieve 4-5 CMS Star Ratings. Together, the platform serves more than 45 health plans (including five National Health Plans, seven Blues Plans, and two National PBMs) and has touched more than 30 million lives while producing more than 40 million recommendations annually.

Differentiator

Problem solved

Functional benefit

Brands

• LUMINATE: High-Risk Patient Management Software that uncovers opportunities to support high-risk, high-cost patients and rapidly reduce hospitalizations.
• RESONATE
• ELEVATE

Products and services

• Arine Platform (Core AI Platform) The underlying AI-driven medication intelligence platform that integrates clinical, behavioral, and social data (including Social Determinants of Health) with deep clinical expertise to deliver personalized medication recommendations at scale. It has touched more than 30 million lives and produces more than 40 million recommendations annually across the LUMINATE, RESONATE, and ELEVATE solutions.
• Arine LUMINATE High-risk patient management solution that uses AI models leveraging hundreds of data features to identify patients at imminent risk of medication-related problems. Enables high-velocity interventions through automatically generated care plans, with reported outcomes of >40% reduction in hospitalizations and >10% decrease in total cost of care within six months.
• Arine RESONATE Prescriber analytics platform that uses AI algorithms to identify outlier prescribing patterns and deliver focused, high-impact patient recommendations to providers. Yields >50% provider recommendation acceptance rates and has demonstrated 20-30% reductions in behavioral health costs.
• Arine ELEVATE Quality improvement solution focused on helping health plans achieve 4-5 CMS Star Ratings across Part C and Part D measures for Medicare Advantage, Medicaid, and other populations. Analyzes social, clinical, and behavioral data to understand member risk trajectories and delivers just-in-time interventions through predictive algorithms.
• Arine Medication Therapy Management (MTM) Medication Therapy Management solution that optimizes MTM programs by automating components of medication reviews and generating member education materials and prescriber communications. Reported outcomes include 86-93% CMR completion rates and 5-10x improvement in care team efficiency performing CMRs.

Quantifiable outcome

• >10% decrease in Total Cost of Care
• +12 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Partnerships

Five partnerships are on record, tiered major named partnership, major named partnership / flagship client and compliance / certification relationship.

• Priority Healthmajor named partnershipStrategic or Co-development Partner · 1 August 2022Named alongside Blue Shield of California as a health plan partner announced in conjunction with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.
• Blue Shield of Californiamajor named partnershipStrategic or Co-development Partner · 1 August 2022Named alongside Priority Health as a health plan partner announced with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.
• Magellan Healthmajor named partnershipStrategic or Co-development PartnerWorking with Arine on the whole patient journey for behavioral health, using data and technology to identify elevated risk between sessions. Featured in a Magellan Health webinar on behavioral health.
• SCAN Health Planmajor named partnership / flagship clientStrategic or Co-development PartnerMedicare-focused health plan using Arine to deliver high-quality care to its Medicare population, achieving 92% adherence to antihypertensives and 92% CMR completion rate for MTM.
• HITRUST Alliancecompliance / certification relationshipTechnology or IntegrationArine has earned HITRUST Risk-based, 2-year (r2) Certification for its Arine Portal, demonstrating compliance with healthcare information security requirements.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• DrFirst: DrFirst delivers medication intelligence, e-prescribing, and clinical data solutions used by providers, health plans, and PBMs. Comparable to Arine on medication data integration and prescriber-facing workflows.
• Tabula Rasa HealthCare (now ExactCare): Tabula Rasa HealthCare / ExactCare provides medication management, MTM, and pharmacovigilance services to health plans and at-risk provider organizations. Highly comparable on medication optimization, especially for high-risk and senior populations.
• Memora Health: Memora Health offers AI-powered patient engagement and care navigation for health systems and payers. Comparable to Arine on AI-driven clinical workflow automation and value-based care deployments.
• Cohere Health: Cohere Health applies AI to prior authorization and utilization management for health plans. Comparable to Arine as an AI-native enterprise SaaS platform selling into payer clinical and pharmacy buyers with outcome-aligned contracts.
• RxAnte: RxAnte is a healthcare analytics company focused on medication adherence and quality measurement for health plans and PBMs. It is the closest direct peer to Arine's adherence, Star Ratings, and MTM-focused offerings.
• Bamboo Health: Bamboo Health provides real-time care coordination, behavioral health, and SDOH-informed intelligence to health plans and providers. Comparable to Arine on integrating behavioral and social data to drive medication-related and total-cost-of-care outcomes.

Broad incumbents

• Surescripts: Surescripts operates the dominant U.S. health information network for e-prescribing and medication intelligence, used by virtually all PBMs and most health plans. Comparable to Arine as an incumbent medication data and intelligence infrastructure layer that could compete or partner.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving health systems and payers on quality, cost, and value-based care. Comparable as a broad incumbent in healthcare analytics that overlaps with Arine's quality and population health modules.
• Olive AI: Olive AI deploys AI-driven workflow automation across healthcare operations, including revenue cycle and clinical workflows. Comparable to Arine as a healthcare AI platform selling into enterprise health systems, though with broader horizontal scope.

Emerging players

• Apixio (Centene): Apixio applies AI to clinical data extraction, risk adjustment, and quality measurement for payers. Comparable to Arine on AI-driven quality and risk analytics for health plans, particularly in Medicare Advantage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/arinehealth
• LinkedInlinkedin.com/company/arinehealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arine